Lucas Marshall

Oral fluid drug testing of chronic pain patients. II. Comparison of paired oral fluid and urine specimens.

R. Heltsley, E. Cone, Y. Caplan, 2012, Journal of analytical toxicology.

Oral fluid drug testing of chronic pain patients. I. Positive prevalence rates of licit and illicit drugs.

R. Heltsley, E. Cone, Y. Caplan, 2011, Journal of analytical toxicology.

Evidence of Designer Benzodiazepine Use in Routine Healthcare Urine Drug Specimens

Jeneva M. Garland, A. Holt, Lucas Marshall, 2021, Journal of addiction medicine.

Prevalence of synthetic cannabinoids in U.S. athletes: initial findings.

R. Heltsley, T. Robert, M. Shelby, 2012, Journal of analytical toxicology.

Stakeholder surveys of Canadian healthcare performance: what are they telling us? Who should be listening? Who should be acting, and how?

Sara Ahmed, J. Nemis-White, T. Montague, 2014, Healthcare quarterly.

Recent Health Care Trends in Canada: Perceptions of Quality, Access and Affordability; and, Priorities for Improvement, 1998-2014

Sara Ahmed, J. Nemis-White, T. Montague, 2015 .

Searching for Best Direction in Healthcare: Distilling Opportunities, Priorities and Responsibilities.

Sara Ahmed, J. Nemis-White, T. Montague, 2016, Healthcare quarterly.

Oral fluid drug testing of chronic pain patients. I. Positive prevalence rates of licit and illicit drugs.

R. Heltsley, E. Cone, Y. Caplan, 2011, Journal of analytical toxicology.